2023-08-08 16:39:08 ET
- BioLife Solutions press release ( NASDAQ: BLFS ): Q2 GAAP EPS of -$0.23 misses by $0.02 .
- Revenue of $39.51M (-2.4% Y/Y) misses by $3.82M .
- Total revenue for the second quarter of 2023 was $39.5 million, a decrease of $1.0 million, or 3%, from $40.5 million for the second quarter of 2022. There was no COVID-19 related revenue in the second quarter of 2023. Ex-COVID related revenue growth for the second quarter of 2023 was 7%.
-
BioLife Solutions is updating 2023 revenue guidance, which is based on expectations for its existing business.
Total revenue for 2023 is expected to range from $144 million to $158 million vs. $184.14M consensus, reflecting a year-over-year decrease of 11% to 2%. Excluding COVID-19-related revenue, this range reflects a year-over-year decrease of 3% to an increase of 6%.
For further details see:
BioLife Solutions GAAP EPS of -$0.23 misses by $0.02, revenue of $39.51M misses by $3.82M